DUBLIN--(BUSINESS WIRE)--The "Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%.
The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.
The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period.
The cardiac mapping products market has been segmented into contact with cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.
The atrial fibrillation applications segment held the largest market share in 2018.
By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.
The North American cardiac mapping market is expected to hold the largest share during the forecast period.
Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.
Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cardiac mapping market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Key Topics Covered:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Research Methodology Steps
2.3 Market Data Estimation and Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: European Cardiac Mappingmarket, By Indication & Country (2019)
4.3 Market Share, By Type, 2019 vs. 2024
4.4 Market Share, By Indication, 2019 vs. 2024
4.5 Geographic Outlook: Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 New Entrants in the Market
5.2.1.2 Growing Investments, Funds, and Grants
5.2.1.3 Increasing Incidence of Target Diseases
5.2.1.4 Growth in the Geriatric Population
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.2.2 Lack of Skilled and Experienced Electrophysiologists
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Technological Advancements
5.2.4 Challenges
5.2.4.1 Unfavorable Regulatory Scenario
5.2.4.2 Alternative Technologies
6 Cardiac Mapping Market, By Type
6.1 Introduction
6.2 Contact Cardiac Mapping Systems
6.3 Non-Contact Cardiac Mapping Systems
7 Cardiac Mapping Market, By Indication
7.1 Introduction
7.2 Atrial Fibrillation
7.3 Atrial Flutter
7.4 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
7.5 Other Arrhythmias
8 Cardiac Mapping Market, By Region
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
9.1 Introduction
9.2 Market Ranking Analysis
9.3 Competitive Leadership Mapping (Overall Market)
9.4 Competitive Scenario
10 Company Profile
10.1 Biosense Webster, Inc. (A Johnson & Johnson Company)
10.2 Abbott Laboratories
10.3 Medtronic Plc
10.4 Boston Scientific Corporation
10.5 Microport Scientific Corporation
10.6 EP Solutions Sa
10.7 Acutus Medical
10.8 Koninklijke Philips N.V.
10.9 Lepu Medical
10.1 Biotronik
10.11 Angiodynamics
10.12 Biosig Technologies, Inc.
10.13 APN Health, LLC
10.14 Coremap
10.15 Kardium, Inc.
10.16 Catheter Precision, Inc.
10.17 Epmap-System
For more information about this report visit https://www.researchandmarkets.com/r/7cyth0
